Literature DB >> 24491680

(33)S as a cooperative capturer for BNCT.

J Praena1, M Sabaté-Gilarte2, I Porras3, P L Esquinas4, J M Quesada5, P Mastinu6.   

Abstract

(33)S is a stable isotope of sulfur for which the emission of an α-particle is the dominant exit channel for neutron-induced reactions. In this work the enhancement of both the absorbed and the equivalent biologically weighted dose in a BNCT treatment with 13.5keV neutrons, due to the presence of (33)S, has been tested by means of Monte Carlo simulations. The kerma-fluence factors for the ICRU-4 tissue have been calculated using standard weighting factors. The simulations depend crucially on the scarce (33)S(n,α)(30)Si cross-section data. The presence of a high resonance at 13.5keV was established by previous authors providing discrepant resonance parameters. No experimental data below 10keV are available. All of this has motivated a proposal of experiment at the n_TOF facility at CERN. A setup was designed and tested in 2011. Some results of the successful test will be shown. The experiment is scheduled for the period November to December 2012.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cross-section measurement; Epithermal neutron beam; Monte Carlo simulations; Neutron capture therapy

Mesh:

Substances:

Year:  2014        PMID: 24491680     DOI: 10.1016/j.apradiso.2013.12.039

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  2 in total

Review 1.  Physical, dosimetric and clinical aspects and delivery systems in neutron capture therapy.

Authors:  Bagher Farhood; Hadi Samadian; Mahdi Ghorbani; Seyed Salman Zakariaee; Courtney Knaup
Journal:  Rep Pract Oncol Radiother       Date:  2018-08-01

2.  Measurement of the (33)S(n,α) cross-section at n_TOF(CERN): Applications to BNCT.

Authors:  Marta Sabaté-Gilarte; Javier Praena; Ignacio Porras; José Manuel Quesada; Pierfrancesco Mastinu
Journal:  Rep Pract Oncol Radiother       Date:  2014-09-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.